
WCD 2019

Featured articles


Insights into pathogenesis of AD define novel therapeutic targets
CONTENTS
Online First
Treating Psoriasis in 2019

Choosing the right biologic in psoriasis
Registries – an important research tool in biologics
Atopic Dermatitis – What is New

Insights into pathogenesis of AD define novel therapeutic targets
Combinations are hot in AD treatment
Dermal Reactions to Systemic Drugs
Cutaneous adverse events due to EGFR inhibitors
Management strategies for drug-induced mucositis
Skin toxicity of immune checkpoint inhibitors
Lupus Erythematosus Today
New targets and biologics for cutaneous lupus erythematosus

Novel lupus classification will aid future research
Hidradenitis Suppurativa
Various guidelines with much overlap
Antibiotics in hidradenitis suppurativa

Biologicals beyond TNF blockade
Small Molecules – What to Expect
Novel treatment options for many dermatologic indications
Long awaited oral therapy for moderate-to-severe AD
Novel treatment options in alopecia areata and vitiligo
Optimising the Management of Keloids

Keloids: a faulty switch in wound healing?
Treating keloids with injections
Treating keloids with lasers
What the future of keloid treatment could hold
Malignant Melanoma – Advances in Management
Will malignant melanoma become a curable disease?
Surgical management of melanoma
Best of the Posters
